ArticleERJ open research2026
Pre-diagnosed sleep apnoea is linked to severe courses in community-acquired pneumonia.
Article in ERJ open research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum issued
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Sleep-disordered breathing (SDB) is associated with adverse outcomes in cardiopulmonary diseases, but its prognostic relevance in community-acquired pneumonia (CAP) is not well established. This study investigates whether pre-diagnosed SDB increases the risk for severe CAP. Methods: In the prospective CAPNETZ cohort, 4686 adult patients with radiologically confirmed CAP were assessed for pre-existing SDB and continuous positive airway pressure (CPAP) therapy. Outcomes included intensive care unit (ICU) admission, mechanical ventilation (MV) and 28-day mortality. Univariable and multivariable logistic regression analyses were performed. Results: SDB was present in 120 patients (2.6%), and 74 (1.6%) had established CPAP therapy. SDB was significantly associated with ICU admission and MV, but not with 28-day mortality in univariate analyses. In multivariable models, SDB (OR 1.46, 95% CI 2.35-3.80), male sex, confusion and older age were independently associated with ICU admission. Similarly, SDB (OR 5.16, 95% CI 2.99-8.89), male sex, confusion, older age, tachypnoea and elevated heart rate were linked to MV. CPAP therapy did not emerge as an independent predictor in multivariable analysis. Mortality within 28 days was independently associated only with confusion, older age and malignancy. Conclusion: Our results highlight SDB as a potential novel risk factor for severe courses of CAP, including the need for ICU and MV. It suggests that SDB should be considered a critical component in the risk stratification and management of CAP and that established CPAP treatment may have a protective effect. Additional study data are needed to further substantiate these findings.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.